Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia

Molecular Psychiatry

Volumn 6, Issue 3, 2001, Pages 293-301

  Mirnics, K ^a   Middleton, F A ^a   Stanwood, G D ^a   Lewis, D A ^a   Levitt, P ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

1q21 22; Antipsychotic; Cerebral cortex; Gene expression; Haloperidol; Major depression; Microarray; Prefrontal; Regulator of G protein signaling; RGS4; Schizophrenia; Susceptibility gene

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT; RGS PROTEIN;

ADULT; ARTICLE; CHROMOSOME 1Q; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; MONKEY; NEUROMODULATION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; ANIMALS; ANTIPSYCHOTIC AGENTS; CHROMOSOMES, HUMAN, PAIR 1; DEPRESSIVE DISORDER, MAJOR; FAMILY HEALTH; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GTP-BINDING PROTEINS; HALOPERIDOL; HUMANS; MACACA FASCICULARIS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREFRONTAL CORTEX; RGS PROTEINS; SCHIZOPHRENIA;

EID: 0035061298     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000866     Document Type: Article

References (59)

1. Catching up on schizophrenia
2. The NIMH perspective: Next steps in schizophrenia research
3. Is there a neuropathology of schizophrenia?
4. Schizophrenia: A neurodevelopmental perspective
5. From neuropathology to neurodevelopment
6. The frontal lobes and schizophrenia
7. Functional and anatomical aspects of prefrontal pathology in schizophrenia
8. Decreased dendritic spine density of prefrontal cortical pyramidal neurons in schizophrenia
9. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy
10. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex
11. Dopamine, the prefrontal cortex and schizophrenia
12. Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia
13. Serotonin model of schizophrenia: Emerging role of glutamate mechanisms
14. The GTPase-activating protein RGS4 stabilizes the transition state for nucleotide hydrolysis
15. GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits
16. The regulator of G protein signaling family
17. Divergence of RGS proteins: Evidence for the existence of six mammalian RGS subfamilies
18. Regulators of G-protein signaling (RGS) proteins: Region-specific expression of nine sub-types in rat brain
19. RGS proteins: More than just GAPs for heterotrimeric G proteins
20. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)
21. Glutamate receptor update
22. GABAB receptors
23. Dopamine receptors: From structure to function
24. Brain receptors for antipsychotic drugs and dopamine: Direct binding assays
25. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs
26. Serotonergic basis of antipsychotic drug effects in schizophrenia
27. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22
28. Decreased GAD67 mRNA expression in a subset of prefrontal cortical GABA neurons in schizophrenia
29. Tottering mouse motor dysfunction is abolished on the Purkinje cell degeneration (pcd) mutant background
30. Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects
31. Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical disectors
32. Stereological studies of the schizophrenic brain
33. A G-protein signaling network mediated by an RGS protein
34. Increase in [3H]cAMP binding sites and decrease in Gi alpha and Go alpha immunoreactivities in left temporal cortices from patients with schizophrenia
35. Isotype-specific G protein abnormalities in the left superior temporal cortex and limbic structures of patients with chronic schizophrenia
36. Reduced concentrations of the alpha-subunit of GTP-binding protein Go in schizophrenic brain
37. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics
38. Bimodal distribution of dopamine receptor densities in brains of schizophrenics
39. From the cover: Increased baseline occupancy of D2 receptors by dopamine in schizophrenia
40. The neuropathology of schizophrenia. A critical review of the data and their interpretation
41. Analysis of gene expression in multiple sclerosis lesions using cDNA microarrays
42. Exploring the new world of the genome with DNA microarrays
43. Mice, microarrays, and the genetic diversity of the brain
44. 2+/calmodulin reverses PIP3-dependent inhibition of RGS GAP activity
45. The regulator of G protein signaling RGS4 selectively enhances alpha2A adrenoceptor stimulation of the GTPase activity of Go1alpha and Gi2alpha
46. RGS proteins determine signaling specificity of Gq-coupled receptors
47. Beyond the dopamine receptor: The DARPP-32/protein phosphatase-1 cascade
48. Differential localization of the mRNAs for the pertussis toxin insensitive G-protein alpha subunits Gq, G11, and Gz in the rat brain, and regulation of their expression after striatal deafferentation
49. Light and electron microscopic localization of alpha subunits of GTP-binding proteins, G(o) and Gi, in the cerebral cortex and hippocampus of rat brain
50. Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors
51. Rapid release of antipsychotic drugs from dopamine D2 receptors: An explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine
52. The role of serotonin in antipsychotic drug action
53. Search for schizophrenia succeptability genes
54. 31P nuclear magnetic resonance spectroscopy: Neurodevelopment and schizophrenia
55. Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence?
56. Synaptic density in human frontal cortex - Developmental changes and effects of aging
57. Formation, elimination and stabilization of synapses in the primate cerebral cortex
58. Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood
59. Gene expression changes in adult prefrontal cortex and nucleus accumbens following neonatal ventral hippocampal lesions